Amarin Corp. Plc (AMRN)
12.15
+0.06
(+0.50%)
USD |
NASDAQ |
Oct 06, 12:15
Amarin Price : 12.15 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 12.29 | 12.34 | 12.00 | 12.09 | 79841.00 |
| Oct 02, 2026 | 13.00 | 13.02 | 12.31 | 12.35 | 100386.0 |
| Oct 01, 2026 | 13.00 | 13.04 | 12.63 | 12.72 | 77327.00 |
| Sep 30, 2026 | 13.01 | 13.23 | 12.98 | 13.00 | 62544.00 |
| Sep 29, 2026 | 13.24 | 13.28 | 13.04 | 13.14 | 19816.00 |
| Sep 28, 2026 | 13.19 | 13.47 | 13.06 | 13.25 | 22788.00 |
| Sep 25, 2026 | 13.40 | 13.40 | 13.00 | 13.20 | 127282.0 |
| Sep 24, 2026 | 13.58 | 13.63 | 13.40 | 13.43 | 47936.00 |
| Sep 23, 2026 | 13.71 | 13.81 | 13.50 | 13.72 | 59839.00 |
| Sep 22, 2026 | 13.52 | 13.90 | 13.52 | 13.75 | 59062.00 |
| Sep 21, 2026 | 13.63 | 13.80 | 13.38 | 13.48 | 38789.00 |
| Sep 18, 2026 | 13.84 | 13.90 | 13.58 | 13.63 | 50665.00 |
| Sep 17, 2026 | 13.92 | 13.95 | 13.72 | 13.87 | 24336.00 |
| Sep 16, 2026 | 13.97 | 14.08 | 13.78 | 13.84 | 45089.00 |
| Sep 15, 2026 | 13.95 | 13.97 | 13.72 | 13.93 | 41106.00 |
| Sep 14, 2026 | 13.76 | 14.08 | 13.76 | 14.00 | 38270.00 |
| Sep 11, 2026 | 14.09 | 14.10 | 13.68 | 13.80 | 49370.00 |
| Sep 10, 2026 | 14.27 | 14.30 | 13.90 | 14.04 | 51753.00 |
| Sep 09, 2026 | 14.17 | 14.40 | 14.07 | 14.39 | 33687.00 |
| Sep 08, 2026 | 13.52 | 14.30 | 13.19 | 14.25 | 99807.00 |
| Sep 04, 2026 | 13.67 | 13.85 | 13.52 | 13.63 | 80560.00 |
| Sep 03, 2026 | 13.68 | 13.87 | 13.60 | 13.71 | 48444.00 |
| Sep 02, 2026 | 13.88 | 14.02 | 13.68 | 13.70 | 45613.00 |
| Sep 01, 2026 | 13.81 | 14.19 | 13.81 | 13.84 | 39938.00 |
| Aug 31, 2026 | 13.97 | 14.32 | 13.73 | 13.88 | 40870.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Neurocrine Biosciences, Inc. | 143.63 |
| Alkermes Plc | 42.04 |
| Liquidia Corp. | 26.55 |
| Akari Therapeutics Plc | 8.56 |
| DBV Technologies SA | 10.05 |
Price Related Metrics
| PS Ratio | 1.362 |
| Price to Book Value | 0.5752 |
| Price to Free Cash Flow | 16.28 |
| Earnings Yield | -10.68% |
| Market Cap | 255.18M |